Regenerative Medical Technology Group Inc.
RMTG
$0.04
$0.003.00%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 5.04M | 4.84M | 4.84M | 4.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 5.04M | 4.84M | 4.84M | 4.65M |
| Cost of Revenue | -- | 2.03M | 1.59M | 1.59M | 1.46M |
| Gross Profit | -- | 3.01M | 3.26M | 3.26M | 3.20M |
| SG&A Expenses | -- | 2.97M | 2.76M | 2.76M | 2.65M |
| Depreciation & Amortization | -- | 154.90K | 167.60K | 167.60K | 195.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 5.15M | 4.51M | 4.51M | 4.30M |
| Operating Income | -- | -112.90K | 331.00K | 331.00K | 350.30K |
| Income Before Tax | -- | -7.06M | -3.59M | -3.59M | -4.36M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -7.06 | -3.59 | -3.59 | -4.36 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -7.06M | -3.59M | -3.59M | -4.36M |
| EBIT | -- | -112.90K | 331.00K | 331.00K | 350.30K |
| EBITDA | -- | 124.90K | 581.50K | 581.50K | 629.00K |
| EPS Basic | -- | -0.56 | -0.29 | -0.29 | -0.35 |
| Normalized Basic EPS | -- | -0.33 | -0.18 | -0.18 | -0.22 |
| EPS Diluted | -- | -0.56 | -0.29 | -0.29 | -0.35 |
| Normalized Diluted EPS | -- | -0.33 | -0.18 | -0.18 | -0.22 |
| Average Basic Shares Outstanding | -- | 50.16M | 50.16M | 50.16M | 50.11M |
| Average Diluted Shares Outstanding | -- | 50.16M | 50.16M | 50.16M | 50.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |